Polypharmacy that results in inappropriate therapy is related to age, comorbidity, disability and number of medications. Polypharmacy increases the likelihood of residential care placement, impaired mobility, morbidity, hospitalization and death. In this course for health and helping professionals, you’ll gain tools to evaluate patients with multiple medications, accounting for evidence for benefit, goals of therapy and possible harms attributed to the medication. Discussion around avoiding the prescribing cascade that can lead to polypharmacy, the importance of following-up medication trials to ensure the goals of therapy are being met and the patient is not being caused harm will also be covered.
Course withdrawal must occur at least 48 hours prior to course commencement to receive a refund less a $25 administration fee.
Continuing Studies statement on use of educational technology
This course will require the use of Zoom and may use other education technology such as internet-based applications, cloud services, or social media. In order to complete this course you will be required to either consent to the disclosure of your personal information outside of Canada to enable use of these technologies, or work with the Division of Continuing Studies to explore other privacy protective options (such as using an alias or nickname).